L-Tyrosine for Depression

Verdict: Does not work for depression

L-tyrosine does not appear to relieve depression. Despite being a precursor to dopamine and other catecholamines, the only controlled trial found no antidepressant benefit, so it should not be used to treat depression.

D 🔴 D Counter-Evidence Counter-Evidence

🔬Why this grade7-layer evidence engine

The grade reflects direct counter-evidence rather than a simple lack of data. The single double-blind randomized controlled trial (PMID 2142699; Gelenberg 1990, n=65, 4 weeks, tyrosine vs. imipramine vs. placebo) found no antidepressant activity: tyrosine raised MHPG excretion, a catecholamine marker, but this biochemical change did not translate into clinical improvement. The only positive signals come from an uncontrolled 1982 narrative review (PMID 6764934) and a 1980 Lancet letter (PMID 6107536), both low-quality and superseded by the negative trial.

Regulators support safety, not efficacy. The US FDA lists L-tyrosine only as a permitted nutrient supplement and flavoring agent, granting no health claim for mood. EFSA accepts that tyrosine contributes to normal dopamine and catecholamine synthesis in a protein-adequate diet, but this is a physiological precursor statement, not evidence of antidepressant effect, and EFSA notes typical European diets already supply enough protein. The UK NHS cannot recommend tyrosine supplementation, citing inadequate efficacy and safety outcome data.

Clinical guidance is essentially silent: major centers and psychiatric bodies do not endorse tyrosine for depression. The evidence base is also old (1980-1990) with no modern RCT or meta-analysis. One safety caution matters here: combining tyrosine with MAOI antidepressants carries a risk of hypertensive crisis, which is relevant for people being treated for depression.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.31
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
D · Counter-Evidence
Confidence
79%
Broadly consistent
Evidence level
E3
Single high-quality meta-analysis

How strongly each layer supports this effect

lower = less supportive
L2 PubMedPrimary literature
0.20
L3 MechanismPlausibility
0.25
L11 AI re-checkIndependent read
0.30
L1 ExamineGlobal benchmark
0.50
L5 Clinical bodiesAuthoritative stance
0.55
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.306
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (3)L2 · primary research & systematic reviews

Tyrosine for depression: a double-blind trial
PMID: 2142699 1990 RCT (double-blind) n = 65
Finding: No evidence that tyrosine had antidepressant activity; tyrosine raised MHPG excretion but this did not correlate with clinical improvement.
Government
View on PubMed
Tyrosine for depression
PMID: 6764934 1982 系統性回顧
Finding: Review reporting 'encouraging' early signals for tyrosine in depression based on the catecholamine hypothesis; no controlled outcome data.
🟠 Limited quality Government
View on PubMed
L-tyrosine in depression
PMID: 6107536 1980 Cross-sectional
Finding: Letter only; no abstract or controlled data available.
🟠 Limited quality
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
L-Tyrosine — CAS Reg. No. 60-18-4; 21 CFR 172.320; Permitted Technical Effects: FLAVORING AGENT OR ADJUVANT, NUTRIENT SUPPLEMENT; FEMA No. 3736; FEMA GRAS Publication No. 13; JECFA Flavor No. 1434. source↗
L4b EU EFSA
Neutral
The Panel concludes that a cause and effect relationship has been established between the consumption of L-tyrosine in a protein adequate diet and contribution to normal synthesis of catecholamines / dopamine. No evidence has been provided that the protein supply in the diet of the European population is not sufficient to fulfil this function of the amino acid. For increased attention and contr… source↗
L4c UK NHS
Not addressed
unable to provide any recommendations about whether tyrosine supplementation should be introduced into routine clinical practice owing to no appropriate efficacy or safety outcome measures being evaluated source↗
L4d TW TFDA / 衛福部
Neutral
目前得宣稱之保健功效共有13項:護肝、抗疲勞、調節血脂、調節血糖、免疫調節、骨質保健、牙齒保健、延緩衰老、促進鐵吸收、胃腸功能改善、輔助調節血壓、不易形成體脂肪、輔助調整過敏體質。 source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬3 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-depression-INT-l-tyrosine-001 繁體中文版 →